Edition:
India

Glenmark Pharmaceuticals Ltd (GLEN.NS)

GLEN.NS on National Stock Exchange of India

624.30INR
19 Jan 2018
Change (% chg)

Rs-1.45 (-0.23%)
Prev Close
Rs625.75
Open
Rs630.00
Day's High
Rs631.10
Day's Low
Rs618.50
Volume
320,742
Avg. Vol
1,024,403
52-wk High
Rs972.95
52-wk Low
Rs525.85

Select another date:

Mon, Jan 15 2018

BRIEF-Glenmark Pharma Gets Permission From CDSCO For Phase IIb Dose Range Finding Study For GRC 27864

* GETS PERMISSION BY CENTRAL DRUGS STANDARD CONTROL ORGANIZATION FOR PHASE IIB DOSE RANGE FINDING STUDY FOR GRC 27864 Source text - http://bit.ly/2mEqR6R Further company coverage:

BRIEF-Glenmark Pharmaceuticals Launches Biosimilar Of Adalimumab In India

* LAUNCHES BIOSIMILAR OF ADALIMUMAB IN INDIA Source text for Eikon: Further company coverage:

BRIEF-Glenmark Pharmaceuticals Gets ANDA Approval For Norethindrone Acetate, Ethinyl Estradiol Tablets

* GETS ANDA APPROVAL FOR NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL TABLETS USP AND FERROUS FUMARATE TABLETS Source text - http://bit.ly/2BGPRjs Further company coverage:

BRIEF-Glenmark Pharmaceuticals Meets Primary Clinical Endpoint In Phase 3 Study Of Ryaltris

* SAYS MET ITS PRIMARY CLINICAL ENDPOINT IN A PHASE 3 STUDY EVALUATING SAFETY OF RYALTRIS

BRIEF-Glenmark Pharma Says Closed DCP For Generic Seretide Accuhaler In Nordic Region​

* ANNOUNCES CLOSURE OF DECENTRALISED REGISTRATION PROCEDURE (DCP) FOR GENERIC SERETIDE ACCUHALER IN NORDIC REGION​ Source text - http://bit.ly/2ByD8zw Further company coverage:

BRIEF-Glenmark Pharma Says U.S. FDA issues 7 Form 483 observations for co's ‍Baddi Unit

* GLENMARK PHARMACEUTICALS SAYS ‍BADDI UNIT UNDERWENT AN U.S. FDA AUDIT FROM NOVEMBER 6, 2017 TO NOVEMBER 11, 2017

BRIEF-Glenmark Pharmaceuticals gets ANDA approval for HAILEY Fe 1/20 tablets ​

Nov 22 Glenmark Pharmaceuticals Ltd * Gets ANDA approval for HAILEY Fe 1/20 tablets ​ Source text - http://bit.ly/2hRulnp Further company coverage:

BRIEF-Glenmark Pharmaceuticals gets ANDA approval for Haileytm 24 FE 1 mg/20 mcg​

* Gets ANDA approval for Haileytm 24 fe 1 mg/20 mcg​ Source text for Eikon: Further company coverage:

BUZZ-India's Glenmark Pharma down, Q2 profit falls 4 pct

** Glenmark Pharmaceuticals Ltd falls as much as 3 pct in its biggest intraday pct drop in over a month

BRIEF-India's Glenmark Pharmaceuticals Sept-qtr consol profit falls about 4 pct

* Sept quarter consol profit 2.14 billion rupees versus profit of 2.24 billion rupees last year

Select another date: